Probiotics reduce nasal and eye symptom scores in children with allergic rhinitis
This is a systematic review and meta-analysis of randomized trials in children aged under 18 years with allergic rhinitis. The review synthesized evidence on probiotics, prebiotics, or synbiotics versus placebo for nasal symptom scores, eye symptom scores, quality of life, and serum eosinophils.
The meta-analysis found a significant reduction in nasal symptom scores with a standardized mean difference (SMD) of -1.40 (95% CI: -2.26 to -0.54). Eye symptom scores also showed a significant reduction (SMD = -3.59, 95% CI: -5.84 to -1.33). Quality of life improved significantly (SMD = -2.98, 95% CI: -4.85 to -1.12). Serum eosinophils showed a small but significant increase (SMD = 0.29, 95% CI: 0.06 to 0.52).
The authors acknowledge substantial heterogeneity across studies as a key limitation. Safety data, including adverse events and discontinuations, were not reported. The certainty of evidence is limited by this heterogeneity.
Practice relevance suggests a potential adjunctive role for probiotics, but findings should be interpreted with caution. Further high-quality, standardized trials are needed to confirm effects and clarify immunological markers.